Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01853202 · ClinicalTrials.gov registry record · NA
EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial
A NA study of Cancer Thrombosis, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01853202: Completed NA study of Cancer Thrombosis, sponsored by University of Vermont.
NCT01853202 is a NA study of Cancer Thrombosis that has completed, run by University of Vermont. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01853202, a NA study of Cancer Thrombosis, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with lymphoma or cancer who are receiving chemotherapy in the outpatient setting are at risk for blood clots which form in the veins. The occurrence of blood clots has major implications on personal health including the need for blood thinners and monitoring, potential bleeding, and complications related to blood clots on cardiovascular health. The goal of this study is to determine whether aerobic exercise training is a therapeutic strategy to offset risk of blood clots and improve quality of life among cancer patients during chemotherapy.
Primary Outcome
The primary endpoint will be thrombin generation, a marker of VTE risk in cancer.
Conditions Studied
Interventions
- BEHAVIORAL Supervised aerobic exercise training
Study Locations (1)
Vermont
- Fletcher Allen Healthcare - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-03 |
| Phase | NA |
What the finished NCT01853202 record still lists
NCT01853202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Cancer Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Supervised aerobic exercise training is the first listed.
NCT01853202 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT01853202 about?
NCT01853202 is a clinical study titled "EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial". Patients with lymphoma or cancer who are receiving chemotherapy in the outpatient setting are at risk for blood clots which form in the veins. The occurrence of blood clots has major implications on personal health including the need for blood thinners and monitoring, potential bleeding, and complic...
What is the current status of trial NCT01853202?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-03.
What conditions does trial NCT01853202 study?
This clinical trial studies the following conditions: Cancer Thrombosis.
What interventions are being tested in trial NCT01853202?
The interventions under investigation include: Supervised aerobic exercise training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01853202?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01853202 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01853202's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia